Do GST Polymorphisms Modulate the Frequency of Chromosomal Aberrations in Healthy Subjects? by Vodicka, Pavel et al.
Perspectives | Correspondence
A 384  v o l u m e  117 | n u m b e r  9 | September 2009  •  Environmental Health Perspectives
Do GST Polymorphisms 
Modulate the Frequency of 
Chromosomal Aberrations in 
Healthy Subjects? 
doi:10.1289/ehp.0900838
Rossi et al. (2009) described an association 
between chromosomal aberration (CA) fre-
quency and cancer risk in a case–control 
study on 107 cancer cases and 291 controls, 
whereby they observed no modifying effect of 
poly  morphisms in glutathione S‑transferase 
M1 (GSTM1) and GSTT1. 
In our studies of 488 healthy individuals 
who shared the same environmental expo-
sure in Slovakia and the Czech Republic, 
we observed a CA frequency of 2.35 ± 1.73 
(mean ± SD) (Halasova et al. 2007; Musak 
et al. 2008; Naccarati et al. 2006; Slyskova 
et al. 2007; Vodicka et al. 2001, 2004a, 
2004b). The frequencies (mean ± SD) for 
chromatid-type abberations (CTA) and 
chromosome-type aberrations (CSA) were 
1.22 ± 1.21 and 1.15 ± 1.35, respectively. 
By analyzing modulating effects of genetic 
poly  morphisms in GSTT1, GSTM1, and 
GSTP1 on CAs, CTAs, and CSAs (Table 1), 
we found no significant association between 
chromosomal damage and any of the studied 
polymorphisms. The results were further con-
firmed by logistic regression: for the GSTT1 
null genotype, odds ratio (OR) = 1.35 [95% 
confidence interval (CI), 0.79–2.32; p = 0.27]; 
for the GSTM1 genotype, OR = 1.09 [95% 
CI, 0.74–1.62; p = 0.65]; and for a variant 
GSTP1 Val105Val genotype, OR = 0.83 
[95% CI, 0.55–1.24; p = 0.36]. These data on 
a larger healthy population [previously pub-
lished separately by Halasova et al. (2007), 
Musak et al. (2008), Naccarati et al. (2006), 
Slyskova et al. (2007), and Vodicka et al. 
(2001, 2004a, 2004b)] confirm the findings 
of Rossi et al. (2009) regarding GSTM1 and 
GSTT1 polymorphisms. Additionally, in our 
reanalysis, we did not observe any modulat-
ing effect of GSTP1 polymorphism on CA 
frequency. However, the modu  lating role of 
GST polymorphisms may not be excluded, 
particularly in interaction with heavy occu-
pational exposure. In our study exploring 
chromosomal damage in tire-plant workers 
(Musak et al. 2008), CAs were significantly 
higher in subjects with GSTT1-null than in 
those with GSTT1-plus genotypes, particu-
larly in association with smoking.
In the past decade, CAs have been 
accepted as a predictive marker of cancer 
(Hagmar et al. 2004), particularly for colo-
rectal and lung cancers (Boffetta et al. 2007; 
Norppa et al. 2006). Nevertheless, these 
studies, as well as the study of Rossi et al. 
(2009) may have limitations: For example, 
cohorts were recruited in various regions 
with different life  style and environmental 
backgrounds, and different laboratories were 
involved in processing and scoring the sam-
ples over many years. In earlier studies, vir-
tually no data on individual susceptibility 
were available because of the lack of DNA 
for molecular analysis. 
The data on CAs presented here were 
obtained on healthy subjects from a homo-
geneous region with fairly similar socio-
economic background. The analysis of CAs 
reported in these studies (Halasova et al. 2007; 
Musak et al. 2008; Naccarati et al. 2006; 
Slyskova et al. 2007; Vodicka et al. 2001, 
2004a, 2004b) were performed in two labo- ) were performed in two labo-
ratories, using the same protocol and the same 
scoring criteria with regular slide exchanges 
to minimize inter  laboratory and inter  scorer 
differences. Also, native DNA from whole-
blood samples for molecular genetic studies 
was collected simultaneously with the samples 
for cyto  genetic investigations. 
Future prospective studies regarding CAs 
and cancer should be designed by taking 
into account the life  style and occupational/
environmental exposures, along with fac-
tors of individual susceptibility. Some GST 
polymorphisms may modulate CA fre-
quency through inter  action with environ-
mental factors. The next logical step for a 
confirmation of predictive values of CA 
frequencies in relation to cancer will be 
their determination in lympho  cytes of   
cancer patients in association with clinical– 
pathological characteristics.
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Table 1. Distribution of analyzed genotypes and CA frequencies. 
CA CTA CSA
Genotype No. Mean ± SD χ2 p-Value Mean ± SD χ2 p-Value Mean ± SD χ2 p-Value
GSTT1 deletion
Plus 356 2.26 ± 1.71 1.59 0.21 1.20 ± 1.21 0.88 0.35 1.11 ± 1.28 1.01 0.31
Null   74 2.59 ± 1.84 1.34 ± 1.29 1.29 ± 1.47
GSTM1 deletion
Plus 223 2.28 ± 1.77 0.43 0.51 1.25 ± 1.28 0.01 0.90 1.04 ± 1.32 1.11 0.29
Null 208 2.36 ± 1.70 1.20 ± 1.17 1.18 ± 1.38
GSTP1 Ile105Val
Ile/Ile 176 2.42 ± 1.91 2.25 0.33 1.31 ± 1.38 0.36 0.84 1.12 ± 1.34 1.27 0.53
Ile/Val 219 2.19 ± 1.60 1.14 ± 1.08 1.07 ± 1.36
Val/Val   36 2.58 ± 1.61 1.31 ± 1.31 1.28 ± 1.37
Data, pooled and recalculated from previously published data (Halasova et al. 2007; Musak et al. 2008; Naccarati et al. 
2006; Slyskova et al. 2007; Vodicka et al. 2001, 2004a, 2004b), were analyzed by the Kruskal-Wallis test.Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r  9 | September 2009  A 385
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GST Polymorphisms: Bonassi 
et al. Respond 
doi:10.1289/ehp.0900838R
We thank Vodicka et al. for drawing attention 
to a critical issue—the role of genetic poly-
morphisms in the induction of chromosomal 
damage. 
First, we would like to clarify that our 
study (Rossi et al. 2009) was not designed 
to evaluate the influence of glutathione 
S‑transferase (GST) polymorphisms on 
the frequency of chromosomal aberrations 
(CAs). Instead, we aimed to identify any pos-
sible susceptibility alleles that would increase 
the strength of the relationship between CAs 
and risk of cancer in sub  groups of geneti-
cally variant individuals. The specific pur-
pose of this case–control study explains the 
relative small size: We planned to obtain 
data on both CAs and enetic polymorphisms 
in the same individuals, with all subjects at 
ages appropriate to allow for an informative 
follow-up.
The interesting data reported by Vodicka 
et al. in their letter confirm the extreme 
hetero  geneity of findings when the frequency 
of chromosome damage is associated with 
polymorphisms in genes that influence sev-
eral pathways. In fact, the lack of association 
in the whole database described by Vodicka 
et al. contrasts with the significant results 
reported in exposure-specific subsets, such as 
the highest frequency of CAs in GSTT1-null 
smokers working in the tire industry (Musak 
et al. 2008). This interpretation is also sup-
ported by the study of Iarmarcovai et al. 
(2008a), who reviewed 72 population stud-
ies reporting a significant effect of GSTM1, 
EPHX (microsomal epoxide hydrolase), and 
GSTT1 on micro  nucleus frequency. These 
authors also reported that the effect observed 
in specific pathways—such as ALDH2 in 
connection to chromosome damage due to 
alcohol consumption, BRCA1 and BRCA2 
mutations in breast cancer patients, and 
MTHFR depending on folate levels—was 
much more pronounced.
A great deal of information about the 
role of genetic polymorphisms in the induc-
tion of chromosomal damage will stem from 
genome-wide association studies, when 
enough resources will be available in the 
field to explore the genetic determinants of 
chromo  some damage using a whole genome 
scan. Nevertheless, classical association studies 
are still valid assuming that specific pathways 
are identified, possibly a priori, linking geno-
toxic exposure to polymorphisms of genes 
involved in the correspondent pathway 
We would also like to address future 
strate  gies for exploring the link between the 
frequency of chromosome damage and the risk 
of cancer (and other diseases). We fully agree 
with Vodicka et al.’s recommendation that 
possible modifying effects of lifestyle, occupa-
tional factors, and genetic poly  morphisms be 
taken into account. However, after finding 
negative results concerning the role of occu-
pational exposure to genotoxic agents and 
smoking habit (Bonassi et al. 2000), and poly-
morphisms of metabolic genes (Rossi et al. 
2009), we believe that the remaining factor 
to be investigated is diet. Many studies have 
reported on the role of various food items and 
nutrients as modulators of chromosome stabil-
ity (Fenech 2007); therefore, this parameter 
now has top priority, although reliable data are 
difficult to collect retrospectively. 
The other recommendation from Vodicka 
et al. seems less promising, because measur-
ing the frequency of chromosome damage in 
cancer patients (besides the classi  cal discus-
sion about whether the damage is a cause 
or a consequence of the disease) is possibly 
more a marker of progression than a predic-
tive marker (Iarmarcovai et al. 2008b).
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Green Chemistry: Terminology 
and Principles
doi:10.1289/ehp.0900835
We are grateful to Environmental Health 
Perspectives for implicitly embracing green 
chemistry as a field with profound connec-
tions to the environmental health sciences. 
We also commend the efforts of Wilson and 
Schwarzman (2009) to create greater trans-
parency and accountability around chemi-
cals of concern. We take issue, however, 
with their approach to key scientific con-
cepts and terminology—specifically their 
effort to change the definition of “green 
chemistry.” Precision in terminology is par-
amount for science to function; all parties to 
a scientific discussion must share the same 
set of definitions for knowledge to advance 
effectively.
In their review, Wilson and Schwarzman 
(2009) ignored the original and current defi-
nition of green chemistry, which for almost 
two decades has been recog  nized as a scien-
tific discipline within the field of chemistry. 
Defined in the early 1990s by the U.S. 
Environmental Protection Agency (2009) as 
“the design of chemical products and pro-
cesses that reduce or eliminate the use or 
generation of hazardous substances,” green 
chemistry is now guided by a set of 12 prin-
ciples (Anastas and Warner 1998) that   
are used in both research and teaching in 
chemis  try laboratories around the world.
Based on these principles, dozens of 
universities around the world teach green 
chemistry as a science. Seven graduate pro-
grams offer degrees in green chemistry. Two A 386  v o l u m e  117 | n u m b e r  9 | September 2009  •  Environmental Health Perspectives
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established peer-reviewed scientific jour-
nals focus specifically on research in green 
chemis  try. The impact factor of the journal 
Green Chemistry (published by the Royal 
Society of Chemistry) has increased from 2.5 
to almost 5 over the past 5 years. More than 
1,500 articles on green chemistry have been 
published in the scientific literature over the 
past 15 years. 
Rather than embracing green chemistry’s 
widely used scientific definition, Wilson and 
Schwarzman (2009) instead conflate science 
and policy: 
The laws governing the chemical enterprise help 
define the incentives and disincentives that guide 
economic behavior in the market …. We use the 
term green chemistry in this context:  as an analyti-
cal framework that encompasses both the science of 
safer chemistry and the laws and policies that will 
motivate its development and adoption by society. 
This conflation brings with it two risks. 
First, it undermines clarity in scientific 
communication, something that is espe-
cially important as the fields of environ-
mental health and green chemistry attempt 
to establish cross-disciplinary collabora-
tion. Such collaborations are likely to prove 
vital for both fields. Second, it saddles the 
intellectual and scientific enterprise of 
green chemistry with policy and, poten-
tially, political baggage, as considerations 
of chemical policies unfold in the political 
arena. 
We are most certainly not arguing that 
the science of green chemistry should not 
inform chemical policies. Science and policy 
will be more effective, however, if politi-
cal actors do not muddy accepted scientific 
terminology in service of a political/policy 
agenda, no matter how noble.
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Green Chemistry: Wilson and 
Schwarzman Respond
doi:10.1289/ehp.0900835R
We commend O’Brien, Myers, and Warner 
for their pioneering work identifying chemi-
cal threats to human and ecosystem health 
and for advancing the field of green chemis-
try. In our article (Wilson and Schwarzman 
2009), we discussed advancing green chemis-
try as an objective of chemicals policy and 
described  existing policy barriers that, if 
lifted, would spur the scientific and com-
mercial develop  ment of green chemistry. 
O’Brien et al. recog  nize that the science 
of green chemistry has a role in inform-
ing chemi  cals policies. We would add that 
public policy that accurately reflects current 
science—and the needs of the chemicals 
market—is instrumental to the widespread 
adoption of green chemistry, but dispute 
that green chemistry is integral to chemicals 
policy itself. 
Green chemistry’s potential is expanded 
when the science is embedded in a larger 
context. For example, in an introductory 
text on green chemistry, Lancaster (2002) 
stated that  
Green  chemistry  is  not  a  new  branch  of  
science, but more a new philosophical approach 
that underpins all of chemistry and has techno-
logical, environmental and societal goals.
Lancaster (2002) pointed out that “over the 
last ten years, green chemistry has gradually 
become recognized as both a culture and a 
methodology for achieving sustainability,” 
and that the “12 principles of green chemis-
try help show how this can be achieved” 
(Lancaster 2002). This book addresses techni-
cal aspects of green chemistry while acknowl-
edging the economic, legal, and knowledge 
barriers to advancing green chemistry.
California has adopted a similarly expan-
sive approach. The state’s 2-year old Green 
Chemistry Initiative is rooted in the 12 prin-
ciples of green chemistry, and it also embraces 
a range of tools to ensure the success of green 
chemistry in society. These include new regu-
latory strategies, economic incentives, techni-
cal assistance, research, and education, with 
the goal of “launch[ing] a new chemicals 
framework and a quantum shift in environ-
mental protection” (Adams 2008). These are 
the same kinds of legislative and regulatory 
tools that California has used successfully to 
promote innovation in the energy sector, and 
which the empirical evidence has identified 
are the primary drivers for the adoption of 
cleaner technologies (Nameroff 2004). It is 
in this context that we see the broad potential 
of green chemistry. 
It is a credit to those who have estab-
lished the field of green chemistry that 
multiple interests recognize its value in 
achieving environ  mental and economic sus-
tainability, with benefits for worker health, 
resource conservation, environmental jus-
tice, public health, and global warming. As a 
result, green chemis  try is reaching out from 
a core set of technical principles to inform 
broad societal goals.
As the field of green chemistry gar-
ners increasing attention in the scientific 
community and in society, it is worth rec-
ognizing that the 12 principles of green 
chemistry will be put to use in many con-
texts. We welcome the opportunity to join 
others in engaging with this promising 
field, with its relationship to the environ-
mental health sciences and its role in effec-
tive public policy. 
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Molybdenum Exposure and 
Semen Quality: How Robust Is 
the Evidence of an Effect?
doi:10.1289/ehp.0900922
Meeker et al. (2008) reported on associa-
tions between blood levels of nine different 
metals and four aspects of semen quality 
found in 219 volunteers attending two infer-
tility clinics. Based on the title of their 
article, it seems that the authors claimed 
to have found evidence that molybdenum 
is a male reproductive toxicant. But how 
robust is the evidence? Meeker et al. (2008) 
had no primary prior hypotheses, and their 
study was essentially a “fishing expedition” 
involving many statistical tests of many pos-
sible associations. The authors (Meeker et al. 
2008) did note that “some [findings] may Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r  9 | September 2009  A 387
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be chance findings because of the number 
of comparisons that were made.” A much 
stronger statement is appropriate, namely, 
that it is very likely that some of the findings 
were chance findings. 
The overwhelming majority of study 
subjects (70%) had blood Mo levels below 
the study limit of detection of 1 µg/L. If a 
more sensitive assay method had been used 
[e.g., the method of Case et al. (2001) with 
a detection limit of 0.06 µg/L], then a bet-
ter grouping of subjects could have been 
used in the data analyses. We also believe 
the authors made an inappropriate analytical 
decision. In Table 3 of their article, Meeker 
et al. (2008) summarized analyses in which 
dose-dependent associations for each metal 
were considered in turn while adjusting for 
age and current smoking. The analysis of 
associations between Mo concentrations 
and semen motility were based on data from 
147 subjects. The assumption appears to be 
that 72 (219 – 147) subjects had no useful 
information to provide on the Mo/sperm 
motility issue. It would have been more sci-
entifically rigorous to allow the analysis of 
each semen parameter to make use of data 
from all study subjects, and not just for the 
sake of completeness. The current approach 
has introduced bias into the analysis, because 
different standards are applied to cases [sub-
jects with the adverse health outcome of 
interest (e.g. poor sperm concentration)] and 
controls or referents (subjects without the 
adverse health outcome). To be concrete, in 
the analyses of sperm concentrations, cases 
were allowed to have poor sperm motility, 
whereas controls were not. The effect of 
this, in practice, is to load the controls with 
subjects on high incomes who have never 
smoked. A more standard analysis involv-
ing all study subjects in the analysis of each 
aspect of sperm quality should have been 
carried out. Such an analysis would likely 
have provided very different results to the 
subset analyses they reported. 
In commenting on the linear regression 
analyses shown in their Table 4, Meeker 
et al. (2008) stated that the Mo groups 
“were associated with suggestive decreas-
ing trends in sperm concentration and mor-
phology.” However, examination of the 
table shows that neither of the regression 
coefficients was significantly different from 
zero (i.e., the blood Mo level had no signifi-
cant influence on any of the semen quality 
parameters).
Additional studies would be needed 
to investigate possible effects in semen 
quality based on much larger population 
samples containing a wider range of blood 
Mo levels.
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Semen Quality: Meeker et al. 
Respond
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We appreciate the comments by Sorahan and 
Sullivan that serve to reiterate the limitations 
we discussed in our article reporting relation-
ships between metal concentrations in blood 
and semen quality among 219 men recruited 
through two Michigan infertility clinics 
(Meeker et al. 2008). As highlighted in their 
letter, these limitations included the possibility 
of chance findings due to multiple compari-
sons and the sensitivity of the molybdenum 
assay used, among others. However, dismiss-
ing our analysis as a “fishing expedition” is 
not appropriate, given the animal evidence 
for adverse effects on male reproductive func-
tion in relation to Mo (Institute of Medicine 
2001; Jeter and Davis 1954; Lyubimov et al. 
2004; Pandey and Singh 2002; Thomas and 
Moss 1951; Van Niekerk and Van Niekerk 
1989; Vyskocil and Viau 1999; Yamaguchi 
et al. 2007) and other metals. Because evi-
dence exists for numerous metals to be either 
harmful or beneficial to male reproduction, 
and because metals may interact with one 
another synergistically or antagonistically, we 
conducted this explora  tory study to provide 
the most comprehensive human data to date 
on multiple metals and semen quality. 
Because our study (Meeker et al. 2008) 
was the first to assess the relationship between 
Mo and semen quality in humans, we agree 
that our findings deserve further consider-
ation and scrutiny through future research. 
An added impetus for further investigation 
comes from our recent follow-up analysis in 
which we reported a strong inverse associa-
tion between Mo and circulating testosterone 
in these men, an association that was inde-
pendent of semen quality (Meeker et al. 
2009). Given that testosterone is not strongly 
predictive of semen quality parameters in this 
population (correlation coefficients < 0.15) or 
in other populations (Meeker et al. 2007)—
but it does play a vital role in reproduction 
and other functions in males (e.g., metabolic 
disorders, bone health, endocrine-related 
cancers)—our findings suggest that multiple 
modes of Mo action on male reproduction 
may be possible and should be investigated. 
We considered a number of approaches to 
model the association between metals in blood 
and semen quality parameters. In our logis-
tic regression analysis (Meeker et al. 2008), 
we decided that including only men with all 
three semen quality parameters above refer-
ence values (i.e., “normal”) in the comparison 
group would be most appropriate, because 
the use of a heterogeneous comparison group 
that also includes men with compromised 
semen quality (i.e., at least one parameter 
below reference) may erroneously dilute the 
association between metals and semen quality 
parameters (Hauser et al. 2006). Sorahan and 
Sullivan’s assertion that the use of this more 
homo  genous comparison group, which had 
normal levels of all three parameters, would 
somehow “overload” the comparison group 
with high-income non  smokers in relation 
to the below-reference groups is unfounded 
since these factors were considered in the 
multivariable analyses. Finally, in response to 
Sorahan and Sullivan’s comment regarding 
our Table 4 (Meeker et al. 2008), in small- 
to medium-sized studies it is common prac-
tice to use the term “suggestive” instead of   
“significant” in reporting associations with 
p-values between 0.05 and 0.15. There are 
many instances where relationships with a 
p-value just above 0.05 should not be com-
pletely dis  regarded, especially (as in this case) 
if they are consistent with results from other 
statistical analysis approaches or with previous 
(e.g., animal) research. 
In conclusion, our findings (Meeker 
et al. 2008) may have large public health 
implications, but we agree that our study 
has several limitations. Our results need to 
be replicated in other large human studies, 
and potential biological mechanisms for the 
observed associations, and for metal–metal 
inter  actions, should be investigated in more 
detailed molecular epidemiologic, animal, 
and in vitro studies. Research is also needed 
on important sources, pathways, and routes 
that result in elevated Mo exposure, whether 
it stems from ingestion of naturally occur-
ring or industrially related contamination 
of food and water, intentional ingestion of 
Mo-containing multi  vitamin/multi  mineral 
supplements, potential multi  pathway expo-
sure resulting from the use of Mo in flame A 388  v o l u m e  117 | n u m b e r  9 | September 2009  •  Environmental Health Perspectives
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retardants in building materials or consumer 
products, or a combination of these and 
other scenarios. Research comparing the 
utility of measuring Mo in blood, urine, 
and/or other matrices as biomarkers of Mo 
exposure over relevant time periods of inter-
est is also needed. 
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